SubjectWell Announces New Leadership in Scientific Affairs
SubjectWell is excited to share the news of Matthias Roos's appointment as the new Director of Scientific Affairs. As a company dedicated to enhancing patient recruitment and addressing challenges in clinical development, this addition marks a significant step forward.
Matthias Roos: An Asset to SubjectWell
Matthias Roos will spearhead global research initiatives and lead thought leadership programs tailored to the needs of sponsors, clinical research organizations (CROs), and clinical sites. With a robust background in clinical trial technology, consulting, and strategic leadership, he brings invaluable expertise that positions SubjectWell to tackle the complexities of clinical development.
A Warm Welcome from Leadership
"We're thrilled to welcome Matthias Roos to the SubjectWell team," expressed Fred Martin, CEO of SubjectWell. "His deep understanding of scientific, business, clinical, and regulatory complexities strengthens our ability to transform the industry's approach to clinical development, patient recruitment, and the patient experience."
Extensive Experience in Healthcare and Technology
Matthias's background encompasses healthcare, pharmaceuticals, and clinical trial technology. Before joining SubjectWell, he served as Director of Strategy and trained with Climedo, focusing on launch excellence and innovative solutions for Real-World Evidence and non-interventional studies. His previous role as a Senior Consultant for McKinsey & Company allowed him to assist major clients in refining corporate strategy and optimizing operations.
Academic Achievements and Publications
Matthias Roos holds a Ph.D. in Physics from The Martin Luther University of Halle-Wittenberg and completed research as a Postdoctoral Fellow at the Massachusetts Institute of Technology (MIT). His academic contributions include five peer-reviewed publications. His remarkable achievements have been recognized with prestigious honors, such as the Ernst Award from the German Chemical Society, solidifying his reputation in the field. Over his career, he has authored 15 scientific papers with over 600 citations, showcasing his commitment to knowledge advancement.
About SubjectWell
SubjectWell leads the charge in revolutionizing patient recruitment. The company enhances the experience for sponsors, CROs, and sites through a robust and patient-focused technology platform. With a growing Patient Network of over 13 million patients, SubjectWell offers multilingual patient and site companions, extensive recruiting capabilities in over 102 countries, and an expansive digital media network. These cutting-edge solutions aim to reduce site burden and elevate the patient experience, addressing pressing challenges in patient recruitment.
Media Contacts
For inquiries, please contact the Interdependence Public Relations team: Haylee Elmore and Alysha Eipperle at 602-350-1455.
Frequently Asked Questions
Who is Matthias Roos?
Matthias Roos is the newly appointed Director of Scientific Affairs at SubjectWell, focusing on enhancing patient recruitment strategies.
What is SubjectWell known for?
SubjectWell is known for transforming patient recruitment in clinical development through innovative technology and patient-centered solutions.
What experience does Matthias bring to SubjectWell?
Matthias brings extensive experience from his previous roles in healthcare and clinical trial technology, including leadership in strategy development.
What awards has Matthias Roos received?
Matthias received the Ernst Award from the German Chemical Society and has published numerous scientific papers throughout his career.
How does SubjectWell support clinical trials?
SubjectWell supports clinical trials by providing a comprehensive platform that streamlines recruitment and enhances the patient experience across various study types.
